EV/EBITDA:
-4.15-0.01(-0.24%)Summary
- As of today (June 27, 2025), DNLI EV/EBITDA is -4.15, with a fall of -0.01 (-0.24%) during the most recent trading session on June 26, 2025.
- Over the past year, DNLI EV/EBITDA has increased by +2.07 (+33.28%).
- DNLI EV/EBITDA is now -102.21% below its all-time high of 187.57.
Performance
DNLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DNLI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.2% | +0.3% | +0.3% |
| 1 m1 month | -8.1% | +8.0% | +8.0% |
| 3 m3 months | -5.1% | +5.0% | +4.9% |
| 6 m6 months | +32.1% | -30.8% | -32.0% |
| ytdytd | +27.3% | -25.5% | -28.9% |
| 1 y1 year | +33.3% | -30.8% | -34.1% |
| 5 y5 years | +61.1% | -11.8% | -39.1% |
DNLI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.73 | -11.3% | -4.37 | +5.0% |
| 3 m | 3-month | -3.28 | -26.5% | -4.77 | +13.0% |
| 6 m | 6-month | -3.28 | -26.5% | -6.66 | +37.7% |
| 1 y | 1-year | -3.28 | -26.5% | -9.09 | +54.4% |
| 3 y | 3-year | -3.28 | -26.5% | -29.56 | +86.0% |
| 5 y | 5-year | 187.57 | -102.2% | -47.42 | +91.3% |
| alltime | all time | 187.57 | -102.2% | -58.31 | +92.9% |
DNLI EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -4.15(-27.3%) |
| 2024 | -5.71(-64.3%) |
| 2023 | -15.99(+45.8%) |
| 2022 | -10.97(-39.7%) |
| Date | Value |
|---|---|
| 2021 | -18.19(-113.4%) |
| 2020 | 135.54(-1767.2%) |
| 2019 | -8.13(-83.1%) |
| 2018 | -48.22(+265.0%) |
| 2017 | -13.21 |
FAQ
- What is Denali Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Denali Therapeutics?
- What is DNLI EV/EBITDA year-to-date change?
- What is Denali Therapeutics EV/EBITDA year-on-year change?
What is Denali Therapeutics EV/EBITDA?
The current EV/EBITDA of DNLI is -4.15
What is the all time high EV/EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high EV/EBITDA is 187.57
What is DNLI EV/EBITDA year-to-date change?
Denali Therapeutics EV/EBITDA has changed by +1.56 (+27.32%) since the beginning of the year
What is Denali Therapeutics EV/EBITDA year-on-year change?
Over the past year, DNLI EV/EBITDA has changed by +2.07 (+33.28%)